<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/74389B87-552E-4E14-9FBF-932CCDDA516A"><gtr:id>74389B87-552E-4E14-9FBF-932CCDDA516A</gtr:id><gtr:name>Nuvision Biotherapies Limited</gtr:name><gtr:address><gtr:line1>Medicity, D6 Building,Thane Road</gtr:line1><gtr:city>Nottingham</gtr:city><gtr:postCode>NG90 6BH</gtr:postCode><gtr:region>East Midlands</gtr:region></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/74389B87-552E-4E14-9FBF-932CCDDA516A" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>74389B87-552E-4E14-9FBF-932CCDDA516A</gtr:id><gtr:name>Nuvision Biotherapies Limited</gtr:name><gtr:address><gtr:line1>Medicity, D6 Building,Thane Road</gtr:line1><gtr:city>Nottingham</gtr:city><gtr:postCode>NG90 6BH</gtr:postCode><gtr:region>East Midlands</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>105721.0</gtr:offerGrant><gtr:projectCost>151022.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9AC36490-01A9-4272-809C-DAC97B997BD3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>9AC36490-01A9-4272-809C-DAC97B997BD3</gtr:id><gtr:name>Nu Vision Ophthalmics Limited</gtr:name><gtr:address><gtr:line1>SIR COLIN CAMPBELL BUILDING , TRIUMPH ROAD</gtr:line1><gtr:city>NOTTINGHAM</gtr:city><gtr:postCode>NG7 2TU</gtr:postCode><gtr:region>East Midlands</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>0.0</gtr:offerGrant><gtr:projectCost>0.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/3FC4FA5A-DFED-4F89-A0DF-7B4D191D8244"><gtr:id>3FC4FA5A-DFED-4F89-A0DF-7B4D191D8244</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:surname>Hopkinson</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=132044"><gtr:id>30566E25-0C3B-4A41-8ED5-0C93279B9535</gtr:id><gtr:title>Omnigen: Novel Stem Cell Treatment for Acute Ocular Surface Trauma</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Feasibility Studies</gtr:grantCategory><gtr:grantReference>132044</gtr:grantReference><gtr:abstractText>There are millions of corneal trauma cases globally each year. Without effective treatment, ocular surface trauma can progress to long term complication and corneal blindness. Amniotic membrane has been used in ophthalmic surgery to treat disease and damage to the surface of the eye. Unfortunately clinical usage of amnion has been severely limited as it is not readily available on demand at the hospital, especially in the treatment of an emergency eye injury case. NuVision has noted this restriction and devised OmnigenTM, an immediately accessible, dry amnion-derived product that will have a much greater utility and uptake, making amnion a realistic proposition for adoption by ophthalmic surgeons into emergency medicine</gtr:abstractText><gtr:fund><gtr:end>2017-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2015-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>105721</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">132044</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>